To translate newest research results into the clinical day soon, to analyse data and trials according to the criteria of evidence based medicine and put them in a global context. Presentation of practice-oriented update in diagnosis, treatment as well as follow-up.
Preliminary characterization of pharmacodynamic biomarkers for LR-peptide growth inhibition of ovarian cancer (OC) cells models / Amoroso, Mr; Marverti, G; Genovese, F; Matassa, DANILO SWANN; Helleman, J; Berns, E; Esposito, Franca; Costi, M. P.. - (2013).
Preliminary characterization of pharmacodynamic biomarkers for LR-peptide growth inhibition of ovarian cancer (OC) cells models.
MATASSA, DANILO SWANN;ESPOSITO, FRANCA;
2013
Abstract
To translate newest research results into the clinical day soon, to analyse data and trials according to the criteria of evidence based medicine and put them in a global context. Presentation of practice-oriented update in diagnosis, treatment as well as follow-up.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
